You're viewing a public preview of Astellas Pharma, Inc. Sign up free to access full investment history, financials, executives & more

Astellas Pharma, Inc.

Inactive
2-5-1 Nihonbashi-Honcho,  Chuo-Ku,  103-8411,  Japan
Sector: Life Science Entity: Private
7
M&A Activity
Sign up to view
About Astellas Pharma, Inc.
Operating in the Life Science industry, Astellas Pharma, Inc. is based in Chuo-Ku. It is active in the Life Science space. Corporate transaction records indicate 7 M&A transactions associated with the company. The company is headquartered in Chuo-Ku.
Astellas Pharma, Inc. M&A Activity
7 Acquisitions
# Company Transaction Date Close Date Sector Country
View 7 M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does Astellas Pharma, Inc. do?
Operating in the Life Science industry, Astellas Pharma, Inc. is based in Chuo-Ku. It is active in the Life Science space. Corporate transaction records indicate 7 M&A transactions associated with the company. The company is headquartered in Chuo-Ku.
Where is Astellas Pharma, Inc. headquartered?
Astellas Pharma, Inc. is headquartered in Chuo-Ku, Japan.
When was Astellas Pharma, Inc. founded?
Founded year information for Astellas Pharma, Inc. is available on AcquityData.
What sector is Astellas Pharma, Inc. in?
Astellas Pharma, Inc. operates in the Life Science sector.
Who are the investors in Astellas Pharma, Inc.?
Investor information for Astellas Pharma, Inc. is available to AcquityData members. Sign up for free to access full ownership history.
How many M&A transactions has Astellas Pharma, Inc. been involved in?
Transaction data for Astellas Pharma, Inc. is available to AcquityData members.

Unlock the full Astellas Pharma, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Astellas Pharma, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial